BlossomHill Therapeutics, Inc. (BLSM) vs Oculis Holding AG (OCS)
A side-by-side comparison of BlossomHill Therapeutics, Inc. and Oculis Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLSM
BlossomHill Therapeutics, Inc.
$17.29HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OCS
Oculis Holding AG
$8.72HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BLSM vs OCS
growth of $100 · dividends reinvested · last 1yBLSM +24.6% (+24.6%/yr)OCS -29.1% (-29.1%/yr)BLSM compounded faster over this window
BLSM OCS
BLSM vs OCS: by the numbers
- •BLSM is the larger company ($503M vs $499M market cap).
- •Both run net losses; BLSM's is the smaller (0.00% vs -32724.20% net margin).
Metrics side by side
Valuation
| Metric | BLSM | OCS |
|---|---|---|
| P/S ratio | N/A | 1634.02 |
| P/B ratio | N/A | 1.84 |
Profitability
| Metric | BLSM | OCS |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -32724.20% |
| ROE | N/A | -36.79% |
| ROIC | -43.41% | -39.63% |
Growth (annualized)
| Metric | BLSM | OCS |
|---|---|---|
| Total return CAGR (5Y) | N/A | -2.41% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.